Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hartung

Showing results (141-150 of 178) with videos related to

Pageof 18
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 17, 2003
[Validity of iohexol clearance in patients with chronic renal failure and normal renal function in comparison to (99m)Tc-DTPA-clearance]E Wiendieck, R Hartung, R Fünfstück, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Value of various metabolic parameters in the diagnosis of primary hyperparathyroidism]U Schweigart, T Zilker, R Hartung, et al.
The Journal of Urology|March 1, 1996
Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancerR Hofmann, A Lehmer, R Hartung, et al.
Urologia Internationalis|January 1, 1981
[In vitro and first in vivo experiments for the dissolution of calcium-containing urinary calculi (author's transl)]P Leskovar, R Hartung, M Hropot, et al.
European Urology|January 1, 1997
5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trialJ Breul, G Jakse, G Forster, et al.
Medizinische Klinik|February 13, 1976
[Value and relevance of metabolic function tests in the diagnosis of primary hyperparathyroidism (author's transl)]U Schweigart, U Henderkott, K Paterek, et al.
Urologia Internationalis|April 27, 2000
Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologistC Hofer, P Sauerstein, C Wolter, et al.
World Journal of Surgery|November 9, 2000
New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspectsC Hofer, R Hartung, R Göbel, et al.
Urological Research|January 1, 1992
Modulation of in vitro cell growth of human and murine urothelial tumor cell lines under the influence of interleukin-3, granulocyte-, macrophage- and granulocyte-colony-stimulating factorT Block, F Schmid, B Geffken, et al.
British Journal of Urology|January 12, 1999
Dysfunctional voiding in women: which muscles are responsible?F M Deindl, D B Vodusek, C Bischoff, et al.
Pageof 18

Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Deutsche Medizinische Wochenschrift (1946)|January 17, 2003
[Validity of iohexol clearance in patients with chronic renal failure and normal renal function in comparison to (99m)Tc-DTPA-clearance]E Wiendieck, R Hartung, R Fünfstück, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1975
[Value of various metabolic parameters in the diagnosis of primary hyperparathyroidism]U Schweigart, T Zilker, R Hartung, et al.
The Journal of Urology|March 1, 1996
Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancerR Hofmann, A Lehmer, R Hartung, et al.
Urologia Internationalis|January 1, 1981
[In vitro and first in vivo experiments for the dissolution of calcium-containing urinary calculi (author's transl)]P Leskovar, R Hartung, M Hropot, et al.
European Urology|January 1, 1997
5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trialJ Breul, G Jakse, G Forster, et al.
Medizinische Klinik|February 13, 1976
[Value and relevance of metabolic function tests in the diagnosis of primary hyperparathyroidism (author's transl)]U Schweigart, U Henderkott, K Paterek, et al.
Urologia Internationalis|April 27, 2000
Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologistC Hofer, P Sauerstein, C Wolter, et al.
World Journal of Surgery|November 9, 2000
New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspectsC Hofer, R Hartung, R Göbel, et al.
Urological Research|January 1, 1992
Modulation of in vitro cell growth of human and murine urothelial tumor cell lines under the influence of interleukin-3, granulocyte-, macrophage- and granulocyte-colony-stimulating factorT Block, F Schmid, B Geffken, et al.
British Journal of Urology|January 12, 1999
Dysfunctional voiding in women: which muscles are responsible?F M Deindl, D B Vodusek, C Bischoff, et al.
Pageof 18